GLP-1 inhibitors, such as Ozempic, Wegovy, and Mounjaro, are at the forefront of one of the biggest medical revolutions in recent years. Millions of people already use them to treat diabetes and obesity, but their impact is beginning to extend far beyond weight loss.

In this video, we analyze how they act on the connection between the digestive system and the brain, why they reduce hunger, and what advances laboratories are preparing for the next generation of treatments. We also address their risks, including muscle loss, the potential rebound effect, and the importance of combining them with strength training and proper medical supervision.

But what is truly surprising is that this transformation is already changing consumption habits and forcing the food industry to react. It may even end up affecting economic sectors that seemingly have no connection to these medications.

Furthermore, I share my personal experience with weight loss and explain why I have changed some of my opinion about GLP-1 inhibitors, although I still have significant reservations about their use.

This content is for informational purposes only and does not replace the assessment of a healthcare professional. GLP-1 medications should always be used under prescription and medical supervision.

CHAPTERS

00:00 The Medical Revolution
03:13 About GLP-1s
08:34 How they work and new generations are coming
13:47 Risks, muscle loss, and rebound effect
16:25 The impact that is already changing the economy

Link to my new video blog channel “MANUAL”: @jfcaleromanual

My essential gadgets and equipment for work and life:

https://www.amazon.es/shop/juanfranci...

Support me to make more and better videos on PATREON. Become my mentor:

Patreon: jfcalero

Follow me on INSTAGRAM, TWITTER, or BOTH—it's super easy:
@jfcalero
Don't go to bed without learning something new. If you did, mission accomplished! Thanks for joining me.

#calerocascaron #cascarondenuez #calero